The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells.
Open accessAbstract
The gamma 1(34.5) gene of herpes simplex virus 1 was previously shown to play a role in viral virulence since deletion of the gene reduced by a factor of approximately 100,000 the capacity of the virus to replicate in the central nervous system and cause mortality in the mouse. Here we show that in the human neuroblastoma cell line SK-N-SH of neuronal origin gamma 1(34.5) null mutants expressed early proteins, viral DNA, and mRNA of late genes. However, the onset of viral DNA synthesis triggered complete cessation of incorporation of radioactive precursors into proteins. The mutant and wild-type viruses replicated and could not be differentiated in cell lines or cell strains of nonneuronal origin. The results indicate that in the absence of the gamma 1(34.5) gene the SK-N-SH neuroblastoma cells triggered a response similar to the programed cell death of neuronal cells induced by metabolic stress. The gamma 1(34.5) protein precludes this cell response possibly in order to enable the protein synthesis necessary for viral replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1
McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C., McNab, D., Perry, L. J., Scott, J. E., & Taylor, P. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-7-1531 · Cited by 1,618
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Ejercito, P. M., Kieff, E. D., & Roizman, B. (1968) · Journal of General Virology · doi:10.1099/0022-1317-2-3-357 · Cited by 875
Self-citationProgrammed cell death: Apoptosis and oncogenesis
Williams, G. T. (1991) · Cell · doi:10.1016/0092-8674(91)90002-g · Cited by 826
Chou, J., Kern, E. R., Whitley, R. J., & Roizman, B. (1990) · Science · doi:10.1126/science.2173860 · Cited by 711
Self-citationIL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells.
Duke, R. C., & Cohen, J. (1986) · PubMed · Cited by 382
Inverted Repetitions in the Chromosome of Herpes Simplex Virus
Sheldrick, P., & Berthelot, N. (1974) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1974.039.01.080 · Cited by 356
Herpes simplex virus virion host shutoff function
Kwong, A. D., Kruper, J. A., & Frenkel, N. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.912-921.1988 · Cited by 344
Morse, L. S., Pereira, L., Roizman, B., & Schaffer, P. A. (1978) · Journal of Virology · doi:10.1128/jvi.26.2.389-410.1978 · Cited by 337
Self-citationHoness, R. W., & Roizman, B. (1973) · Journal of Virology · doi:10.1128/jvi.12.6.1347-1365.1973 · Cited by 297
Self-citation
Cited by
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3377 · Cited by 2,634
Expression of baculovirus P35 prevents cell death in Drosophila
Hay, B. A., Wolff, T., & Rubin, G. M. (1994) · Development · doi:10.1242/dev.120.8.2121 · Cited by 1,066
HSV-1 ICP34.5 Confers Neurovirulence by Targeting the Beclin 1 Autophagy Protein
Orvedahl, A., Alexander, D., Tallóczy, Z., Sun, Q., Wei, Y., Zhang, W., Burns, D., Leib, D. A., & Levine, B. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2006.12.001 · Cited by 857
Oncolytic virus therapy: A new era of cancer treatment at dawn
Fukuhara, H., Ino, Y., & Todo, T. (2016) · Cancer Science · doi:10.1111/cas.13027 · Cited by 774
He, B., Gross, M., & Roizman, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.843 · Cited by 751
Self-citationRoulston, A., Marcellus, R. C., & Branton, P. E. (1999) · Annual Review of Microbiology · doi:10.1146/annurev.micro.53.1.577 · Cited by 749
Regulation of apoptosis by viral gene products
Teodoro, J. G., & Branton, P. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1739-1746.1997 · Cited by 629
Rampling, R., Cruickshank, G., Papanastassiou, V, Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301184 · Cited by 598
Control of programmed cell death by the baculovirus genes p35 and iap.
Clem, R. J., & Miller, L. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5212 · Cited by 544
Birnbaum, M. J., Clem, R. J., & Miller, L. K. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2521-2528.1994 · Cited by 536
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
Levine, B., Huang, Q., Isaacs, J. T., Reed, J. C., Griffin, D. E., & Hardwick, J. M. (1993) · Nature · doi:10.1038/361739a0 · Cited by 489
Zhan, Q., Lord, K. A., Alamo, I., Hollander, M. C., Carrier, F., Ron, D., Kohn, K. W., Hoffman, B., Liebermann, D. A., & Fornace, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2361 · Cited by 482
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
Todo, T., Martuza, R. L., Rabkin, S. D., & Johnson, P. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101136398 · Cited by 465
Oncolytic virotherapy: basic principles, recent advances and future directions
Lin, D., Shen, Y., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01407-6 · Cited by 459
Gale, M., & Katze, M. G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00165-4 · Cited by 387
Shen, Y., & Shenk, T. E. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90061-6 · Cited by 320
O'Brien, V (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1833 · Cited by 311
A time to kill: viral manipulation of the cell death program
Hay, S., & Kannourakis, G. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1547 · Cited by 290
Experimental investigation of herpes simplex virus latency
Wagner, E. K., & Bloom, D. C. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.419 · Cited by 284
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
Guo, Z. S., Liu, Z., & Bartlett, D. L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00074 · Cited by 284
Chou, J., Chen, J. J., Gross, M., & Roizman, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10516 · Cited by 284
Self-citationOncolytic herpes simplex virus vectors for cancer virotherapy
Varghese, S., & Rabkin, S. D. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700537 · Cited by 264
Yan, Y., Shetty, M., Harding, H. P., George, G., Zyryanova, A., Labbé, K., Mafi, A., Hao, Q., Sidrauski, C., & Ron, D. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320013121 · Cited by 7
Metadata
- Authors
- Chou, J., & Roizman, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-04-15
- Volume
- 89
- Issue
- 8
- Pages
- 3266-3270
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1998342624
- Cited by
- 393
- References
- 25
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.